Annotation Detail

Information
Associated Genes
DDR2
Associated Variants
DDR2 p.Ser768Arg (p.S768R) ( ENST00000367921.8, ENST00000446985.6, ENST00000367922.7 )
DDR2 p.Ser768Arg (p.S768R) ( ENST00000367921.8, ENST00000367922.7, ENST00000446985.6 )
Associated Disease
lung non-small cell carcinoma
Source Database
CIViC Evidence
Description
In a patient expressing a DDR2 S768R mutation, treatment with dasatinib plus erlotinib acheived a partial response.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/272
Gene URL
https://civic.genome.wustl.edu/links/genes/51
Variant URL
https://civic.genome.wustl.edu/links/variants/145
Rating
3
Evidence Type
Predictive
Disease
Lung Non-small Cell Carcinoma
Evidence Direction
Supports
Drug
Dasatinib,Erlotinib
Evidence Level
C
Clinical Significance
Sensitivity/Response
Pubmed
22328973
Drugs
Drug NameSensitivitySupported
DasatinibSensitivitytrue
ErlotinibSensitivitytrue